Home » Gene and Cell Therapy Services » Lentiviral Vector CDMO Services

Lentiviral Vector CDMO Services

Lentiviral Vector (LVV) CDMO Services

Gene and cell therapy (GCT) has the potential to transform medicine, providing long term and potentially curative treatment options for a wide range of diseases. Lentiviral vector is useful vehicle in delivering gene of interest (GOI) in gene and cell therapies, and therefore, the safety and stable manufacturing of LVV are drawing attention. GenScript ProBio is dedicated to developing adherent and suspension platform to support with the development and manufacturing of lentiviral vector.

Our Services

  • Lentiviral Vector One-stop Solution

    One-stop solution covering process development, analytical development, suspension production, LVV Manufacturing GMP manufacturing and stability test to support regulatory filings.

  • GMP LVV Manufacturing

    GMP lentiviral vector is manufactured compliant to GMP regulations, suitable for early phase clinical trials.

Our Facility and Experience

  • 2,500 m2 state-of-the-art facility dedicated for viral vectors manufacturing
  • Global partners collaborating on viral vector projects
  • Assisted 2 clients to get IND clearance
  • Experience in adherent system and suspension culture system

Our customer service representatives are available 24 hours a day, Monday through Friday, to assist you.

Related Products